| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 13 |
| 1 | SIMVASTATIN | 13 |
| 2 | ROSUVASTATIN | 12 |
| 3 | EVOLOCUMAB | 6 |
| 4 | INCLISIRAN | 4 |
| 5 | ALIROCUMAB | 2 |
| 6 | ASPIRIN | 2 |
| 7 | ASPIRIN 325 MG | 2 |
| 8 | ASPIRIN 81 MG | 2 |
| 9 | EZETIMIBE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INCLISIRAN | 4 | 0.0005 |
| 1 | ROSUVASTATIN | 12 | 0.0001 |
| 2 | ALIROCUMAB | 2 | 0.0001 |
| 3 | RIVAROXABAN | 13 | 0.0001 |
| 4 | SIMVASTATIN | 13 | 0.0001 |
| 5 | EVOLOCUMAB | 6 | 0.0000 |
| 6 | ROSUVASTATIN CALCIUM | 1 | 0.0000 |
| 7 | ZOLEDRONIC ACID | 1 | 0.0000 |
| 8 | EZETIMIBE | 1 | 0.0000 |
| 9 | ASPIRIN | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 8 | 0.0003 |
| 1 | Factor Xa Inhibitor [EPC] | 13 | 0.0000 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 13 | 0.0000 |
| 3 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 | 0.0000 |